Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT03238365 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lip, Oral Cavity and Pharynx
Larynx

Interventions

BIOLOGICAL: Nivolumab
DRUG: Tadalafil
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]